Cybin Inc. (CYBN): Price and Financial Metrics
CYBN Price/Volume Stats
| Current price | $11.16 | 52-week high | $21.66 |
| Prev. close | $11.00 | 52-week low | $6.50 |
| Day low | $10.93 | Volume | 324,700 |
| Day high | $11.48 | Avg. volume | 178,311 |
| 50-day MA | $9.92 | Dividend yield | N/A |
| 200-day MA | $11.79 | Market Cap | 223.11M |
CYBN Stock Price Chart Interactive Chart >
Cybin Inc. (CYBN) Company Bio
Cybin, Inc. is a biotechnology company that focuses on progressing psychedelic therapeutics by utilizing proprietary drug discovery platforms, drug delivery systems, novel formulation approaches and treatment regimens for psychiatric disorders. It operates through the following segments: Serenity Life and Natures Journey. The Serenity Life segment engages in the research and development of pharmaceutical and nutraceutical psilocybin products. The Natures Journey segment focuses on non-psychedelic medical mushroom nutraceutical products. The company was founded by Paul Glavine, Eric So, and John Kanakis on October 13, 2016 and is headquartered in Toronto, Canada.
CYBN Price Returns
| 1-mo | -1.85% |
| 3-mo | 9.58% |
| 6-mo | -17.53% |
| 1-year | -36.11% |
| 3-year | -80.93% |
| 5-year | N/A |
| YTD | -28.37% |
| 2023 | 38.00% |
| 2022 | -75.24% |
| 2021 | -19.46% |
| 2020 | N/A |
| 2019 | N/A |
Loading social stream, please wait...